Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods

<p<<strong<<em<Objectives: </em<</strong<Pre-diabetes is almost always a precursor to the development of type 2 diabetes. Comparison of EZSCAN with existing screening methods for detection of pre-diabetes and diabetes was done.</p<<p<<strong<<em<...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	S. Bajaj [verfasserIn] R. K. Pandey [verfasserIn] A. K. Chaurasia [verfasserIn] R. P. Shukla [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2015

Schlagwörter:	ezscan, diabetes, pre-diabetes

Übergeordnetes Werk:	In: Sri Lanka Journal of Diabetes Endocrinology and Metabolism - Sri Lanka College of Endocrinologists, 2021, 5(2015), 1, Seite 8-12
Übergeordnetes Werk:	volume:5 ; year:2015 ; number:1 ; pages:8-12

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc

DOI / URN:	10.4038/sjdem.v5i1.7266

Katalog-ID:	DOAJ061703672

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ061703672
003	DE-627
005	20230309013317.0
007	cr uuu---uuuuu
008	230228s2015 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.4038/sjdem.v5i1.7266 \|2 doi
035			\|a (DE-627)DOAJ061703672
035			\|a (DE-599)DOAJ9e8799477e1041f9af8fd350e80f3b00
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a RC648-665
100	0		\|a S. Bajaj \|e verfasserin \|4 aut
245	1	0	\|a Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods
264		1	\|c 2015
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a <p<<strong<<em<Objectives: </em<</strong<Pre-diabetes is almost always a precursor to the development of type 2 diabetes. Comparison of EZSCAN with existing screening methods for detection of pre-diabetes and diabetes was done.</p<<p<<strong<<em<Settings and Design: </em<</strong<Cross sectional epidemiological study.</p<<p<<strong<<em<Material and Methods: </em<</strong<All cases underwent the EZSCAN test and had fasting plasma glucose (FBG), post-prandial plasma glucose (PPBG) and HbA1c level estimation. The results of EZSCAN were compared with fasting blood glucose, post-prandial blood glucose and HbA1c levels.</p<<p<<strong<<em<Statistical analysis used: </em<</strong<Mean, Standard deviation, sensitivity, specificity, positive and negative predictive value.</p<<p<<strong<<em<Results: </em<</strong<The sensitivity and specificity of EZSCAN when compared with FBG in diabetes was 87.2% and 87.2% respectively, for pre-diabetes 80.4% and 74.3% respectively and for non-diabetes 51.1% and 97.8% respectively. The sensitivity and specificity of EZSCAN when compared with PPBG in diabetes was 86.5% and 85.2% respectively, for pre-diabetes 76.9% and 72.6% respectively and for non-diabetes 52.8% and 98.9% respectively. The sensitivity and specificity of EZSCAN when compared with HbA1c in diabetes was 86% and 90.2% respectively, for pre-diabetes 87.8% and 71.4% respectively and for nondiabetes 46.3% and 98.8% respectively.</p<<p<<strong<<em<Conclusions: </em<</strong<EZSCAN proved to be a sensitive, specific, easy to perform screening test for diabetes and pre-diabetes which can be performed in non fasting state. EZSCAN is a simple device that can be operated by non medical personnel in non-healthcare settings with minimal subject preparation.</p<<p<Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2015; 5: 4-7</p<
650		4	\|a ezscan, diabetes, pre-diabetes
653		0	\|a Diseases of the endocrine glands. Clinical endocrinology
700	0		\|a R. K. Pandey \|e verfasserin \|4 aut
700	0		\|a A. K. Chaurasia \|e verfasserin \|4 aut
700	0		\|a R. P. Shukla \|e verfasserin \|4 aut
773	0	8	\|i In \|t Sri Lanka Journal of Diabetes Endocrinology and Metabolism \|d Sri Lanka College of Endocrinologists, 2021 \|g 5(2015), 1, Seite 8-12 \|w (DE-627)1762948362 \|x 2012998X \|7 nnns
773	1	8	\|g volume:5 \|g year:2015 \|g number:1 \|g pages:8-12
856	4	0	\|u https://doi.org/10.4038/sjdem.v5i1.7266 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/9e8799477e1041f9af8fd350e80f3b00 \|z kostenfrei
856	4	0	\|u https://sjdem.sljol.info/articles/7266 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2012-998X \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 5 \|j 2015 \|e 1 \|h 8-12

Indexfelder

author_variant	s b sb r k p rkp a k c akc r p s rps
matchkey_str	article:2012998X:2015----::soesafreetoopeibtsndaeeadoprsniht
hierarchy_sort_str	2015
callnumber-subject-code	RC
publishDate	2015
allfields	10.4038/sjdem.v5i1.7266 doi (DE-627)DOAJ061703672 (DE-599)DOAJ9e8799477e1041f9af8fd350e80f3b00 DE-627 ger DE-627 rakwb eng RC648-665 S. Bajaj verfasserin aut Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<<strong<<em<Objectives: </em<</strong<Pre-diabetes is almost always a precursor to the development of type 2 diabetes. Comparison of EZSCAN with existing screening methods for detection of pre-diabetes and diabetes was done.</p<<p<<strong<<em<Settings and Design: </em<</strong<Cross sectional epidemiological study.</p<<p<<strong<<em<Material and Methods: </em<</strong<All cases underwent the EZSCAN test and had fasting plasma glucose (FBG), post-prandial plasma glucose (PPBG) and HbA1c level estimation. The results of EZSCAN were compared with fasting blood glucose, post-prandial blood glucose and HbA1c levels.</p<<p<<strong<<em<Statistical analysis used: </em<</strong<Mean, Standard deviation, sensitivity, specificity, positive and negative predictive value.</p<<p<<strong<<em<Results: </em<</strong<The sensitivity and specificity of EZSCAN when compared with FBG in diabetes was 87.2% and 87.2% respectively, for pre-diabetes 80.4% and 74.3% respectively and for non-diabetes 51.1% and 97.8% respectively. The sensitivity and specificity of EZSCAN when compared with PPBG in diabetes was 86.5% and 85.2% respectively, for pre-diabetes 76.9% and 72.6% respectively and for non-diabetes 52.8% and 98.9% respectively. The sensitivity and specificity of EZSCAN when compared with HbA1c in diabetes was 86% and 90.2% respectively, for pre-diabetes 87.8% and 71.4% respectively and for nondiabetes 46.3% and 98.8% respectively.</p<<p<<strong<<em<Conclusions: </em<</strong<EZSCAN proved to be a sensitive, specific, easy to perform screening test for diabetes and pre-diabetes which can be performed in non fasting state. EZSCAN is a simple device that can be operated by non medical personnel in non-healthcare settings with minimal subject preparation.</p<<p<Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2015; 5: 4-7</p< ezscan, diabetes, pre-diabetes Diseases of the endocrine glands. Clinical endocrinology R. K. Pandey verfasserin aut A. K. Chaurasia verfasserin aut R. P. Shukla verfasserin aut In Sri Lanka Journal of Diabetes Endocrinology and Metabolism Sri Lanka College of Endocrinologists, 2021 5(2015), 1, Seite 8-12 (DE-627)1762948362 2012998X nnns volume:5 year:2015 number:1 pages:8-12 https://doi.org/10.4038/sjdem.v5i1.7266 kostenfrei https://doaj.org/article/9e8799477e1041f9af8fd350e80f3b00 kostenfrei https://sjdem.sljol.info/articles/7266 kostenfrei https://doaj.org/toc/2012-998X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 5 2015 1 8-12
spelling	10.4038/sjdem.v5i1.7266 doi (DE-627)DOAJ061703672 (DE-599)DOAJ9e8799477e1041f9af8fd350e80f3b00 DE-627 ger DE-627 rakwb eng RC648-665 S. Bajaj verfasserin aut Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<<strong<<em<Objectives: </em<</strong<Pre-diabetes is almost always a precursor to the development of type 2 diabetes. Comparison of EZSCAN with existing screening methods for detection of pre-diabetes and diabetes was done.</p<<p<<strong<<em<Settings and Design: </em<</strong<Cross sectional epidemiological study.</p<<p<<strong<<em<Material and Methods: </em<</strong<All cases underwent the EZSCAN test and had fasting plasma glucose (FBG), post-prandial plasma glucose (PPBG) and HbA1c level estimation. The results of EZSCAN were compared with fasting blood glucose, post-prandial blood glucose and HbA1c levels.</p<<p<<strong<<em<Statistical analysis used: </em<</strong<Mean, Standard deviation, sensitivity, specificity, positive and negative predictive value.</p<<p<<strong<<em<Results: </em<</strong<The sensitivity and specificity of EZSCAN when compared with FBG in diabetes was 87.2% and 87.2% respectively, for pre-diabetes 80.4% and 74.3% respectively and for non-diabetes 51.1% and 97.8% respectively. The sensitivity and specificity of EZSCAN when compared with PPBG in diabetes was 86.5% and 85.2% respectively, for pre-diabetes 76.9% and 72.6% respectively and for non-diabetes 52.8% and 98.9% respectively. The sensitivity and specificity of EZSCAN when compared with HbA1c in diabetes was 86% and 90.2% respectively, for pre-diabetes 87.8% and 71.4% respectively and for nondiabetes 46.3% and 98.8% respectively.</p<<p<<strong<<em<Conclusions: </em<</strong<EZSCAN proved to be a sensitive, specific, easy to perform screening test for diabetes and pre-diabetes which can be performed in non fasting state. EZSCAN is a simple device that can be operated by non medical personnel in non-healthcare settings with minimal subject preparation.</p<<p<Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2015; 5: 4-7</p< ezscan, diabetes, pre-diabetes Diseases of the endocrine glands. Clinical endocrinology R. K. Pandey verfasserin aut A. K. Chaurasia verfasserin aut R. P. Shukla verfasserin aut In Sri Lanka Journal of Diabetes Endocrinology and Metabolism Sri Lanka College of Endocrinologists, 2021 5(2015), 1, Seite 8-12 (DE-627)1762948362 2012998X nnns volume:5 year:2015 number:1 pages:8-12 https://doi.org/10.4038/sjdem.v5i1.7266 kostenfrei https://doaj.org/article/9e8799477e1041f9af8fd350e80f3b00 kostenfrei https://sjdem.sljol.info/articles/7266 kostenfrei https://doaj.org/toc/2012-998X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 5 2015 1 8-12
allfields_unstemmed	10.4038/sjdem.v5i1.7266 doi (DE-627)DOAJ061703672 (DE-599)DOAJ9e8799477e1041f9af8fd350e80f3b00 DE-627 ger DE-627 rakwb eng RC648-665 S. Bajaj verfasserin aut Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<<strong<<em<Objectives: </em<</strong<Pre-diabetes is almost always a precursor to the development of type 2 diabetes. Comparison of EZSCAN with existing screening methods for detection of pre-diabetes and diabetes was done.</p<<p<<strong<<em<Settings and Design: </em<</strong<Cross sectional epidemiological study.</p<<p<<strong<<em<Material and Methods: </em<</strong<All cases underwent the EZSCAN test and had fasting plasma glucose (FBG), post-prandial plasma glucose (PPBG) and HbA1c level estimation. The results of EZSCAN were compared with fasting blood glucose, post-prandial blood glucose and HbA1c levels.</p<<p<<strong<<em<Statistical analysis used: </em<</strong<Mean, Standard deviation, sensitivity, specificity, positive and negative predictive value.</p<<p<<strong<<em<Results: </em<</strong<The sensitivity and specificity of EZSCAN when compared with FBG in diabetes was 87.2% and 87.2% respectively, for pre-diabetes 80.4% and 74.3% respectively and for non-diabetes 51.1% and 97.8% respectively. The sensitivity and specificity of EZSCAN when compared with PPBG in diabetes was 86.5% and 85.2% respectively, for pre-diabetes 76.9% and 72.6% respectively and for non-diabetes 52.8% and 98.9% respectively. The sensitivity and specificity of EZSCAN when compared with HbA1c in diabetes was 86% and 90.2% respectively, for pre-diabetes 87.8% and 71.4% respectively and for nondiabetes 46.3% and 98.8% respectively.</p<<p<<strong<<em<Conclusions: </em<</strong<EZSCAN proved to be a sensitive, specific, easy to perform screening test for diabetes and pre-diabetes which can be performed in non fasting state. EZSCAN is a simple device that can be operated by non medical personnel in non-healthcare settings with minimal subject preparation.</p<<p<Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2015; 5: 4-7</p< ezscan, diabetes, pre-diabetes Diseases of the endocrine glands. Clinical endocrinology R. K. Pandey verfasserin aut A. K. Chaurasia verfasserin aut R. P. Shukla verfasserin aut In Sri Lanka Journal of Diabetes Endocrinology and Metabolism Sri Lanka College of Endocrinologists, 2021 5(2015), 1, Seite 8-12 (DE-627)1762948362 2012998X nnns volume:5 year:2015 number:1 pages:8-12 https://doi.org/10.4038/sjdem.v5i1.7266 kostenfrei https://doaj.org/article/9e8799477e1041f9af8fd350e80f3b00 kostenfrei https://sjdem.sljol.info/articles/7266 kostenfrei https://doaj.org/toc/2012-998X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 5 2015 1 8-12
allfieldsGer	10.4038/sjdem.v5i1.7266 doi (DE-627)DOAJ061703672 (DE-599)DOAJ9e8799477e1041f9af8fd350e80f3b00 DE-627 ger DE-627 rakwb eng RC648-665 S. Bajaj verfasserin aut Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<<strong<<em<Objectives: </em<</strong<Pre-diabetes is almost always a precursor to the development of type 2 diabetes. Comparison of EZSCAN with existing screening methods for detection of pre-diabetes and diabetes was done.</p<<p<<strong<<em<Settings and Design: </em<</strong<Cross sectional epidemiological study.</p<<p<<strong<<em<Material and Methods: </em<</strong<All cases underwent the EZSCAN test and had fasting plasma glucose (FBG), post-prandial plasma glucose (PPBG) and HbA1c level estimation. The results of EZSCAN were compared with fasting blood glucose, post-prandial blood glucose and HbA1c levels.</p<<p<<strong<<em<Statistical analysis used: </em<</strong<Mean, Standard deviation, sensitivity, specificity, positive and negative predictive value.</p<<p<<strong<<em<Results: </em<</strong<The sensitivity and specificity of EZSCAN when compared with FBG in diabetes was 87.2% and 87.2% respectively, for pre-diabetes 80.4% and 74.3% respectively and for non-diabetes 51.1% and 97.8% respectively. The sensitivity and specificity of EZSCAN when compared with PPBG in diabetes was 86.5% and 85.2% respectively, for pre-diabetes 76.9% and 72.6% respectively and for non-diabetes 52.8% and 98.9% respectively. The sensitivity and specificity of EZSCAN when compared with HbA1c in diabetes was 86% and 90.2% respectively, for pre-diabetes 87.8% and 71.4% respectively and for nondiabetes 46.3% and 98.8% respectively.</p<<p<<strong<<em<Conclusions: </em<</strong<EZSCAN proved to be a sensitive, specific, easy to perform screening test for diabetes and pre-diabetes which can be performed in non fasting state. EZSCAN is a simple device that can be operated by non medical personnel in non-healthcare settings with minimal subject preparation.</p<<p<Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2015; 5: 4-7</p< ezscan, diabetes, pre-diabetes Diseases of the endocrine glands. Clinical endocrinology R. K. Pandey verfasserin aut A. K. Chaurasia verfasserin aut R. P. Shukla verfasserin aut In Sri Lanka Journal of Diabetes Endocrinology and Metabolism Sri Lanka College of Endocrinologists, 2021 5(2015), 1, Seite 8-12 (DE-627)1762948362 2012998X nnns volume:5 year:2015 number:1 pages:8-12 https://doi.org/10.4038/sjdem.v5i1.7266 kostenfrei https://doaj.org/article/9e8799477e1041f9af8fd350e80f3b00 kostenfrei https://sjdem.sljol.info/articles/7266 kostenfrei https://doaj.org/toc/2012-998X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 5 2015 1 8-12
allfieldsSound	10.4038/sjdem.v5i1.7266 doi (DE-627)DOAJ061703672 (DE-599)DOAJ9e8799477e1041f9af8fd350e80f3b00 DE-627 ger DE-627 rakwb eng RC648-665 S. Bajaj verfasserin aut Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods 2015 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<<strong<<em<Objectives: </em<</strong<Pre-diabetes is almost always a precursor to the development of type 2 diabetes. Comparison of EZSCAN with existing screening methods for detection of pre-diabetes and diabetes was done.</p<<p<<strong<<em<Settings and Design: </em<</strong<Cross sectional epidemiological study.</p<<p<<strong<<em<Material and Methods: </em<</strong<All cases underwent the EZSCAN test and had fasting plasma glucose (FBG), post-prandial plasma glucose (PPBG) and HbA1c level estimation. The results of EZSCAN were compared with fasting blood glucose, post-prandial blood glucose and HbA1c levels.</p<<p<<strong<<em<Statistical analysis used: </em<</strong<Mean, Standard deviation, sensitivity, specificity, positive and negative predictive value.</p<<p<<strong<<em<Results: </em<</strong<The sensitivity and specificity of EZSCAN when compared with FBG in diabetes was 87.2% and 87.2% respectively, for pre-diabetes 80.4% and 74.3% respectively and for non-diabetes 51.1% and 97.8% respectively. The sensitivity and specificity of EZSCAN when compared with PPBG in diabetes was 86.5% and 85.2% respectively, for pre-diabetes 76.9% and 72.6% respectively and for non-diabetes 52.8% and 98.9% respectively. The sensitivity and specificity of EZSCAN when compared with HbA1c in diabetes was 86% and 90.2% respectively, for pre-diabetes 87.8% and 71.4% respectively and for nondiabetes 46.3% and 98.8% respectively.</p<<p<<strong<<em<Conclusions: </em<</strong<EZSCAN proved to be a sensitive, specific, easy to perform screening test for diabetes and pre-diabetes which can be performed in non fasting state. EZSCAN is a simple device that can be operated by non medical personnel in non-healthcare settings with minimal subject preparation.</p<<p<Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2015; 5: 4-7</p< ezscan, diabetes, pre-diabetes Diseases of the endocrine glands. Clinical endocrinology R. K. Pandey verfasserin aut A. K. Chaurasia verfasserin aut R. P. Shukla verfasserin aut In Sri Lanka Journal of Diabetes Endocrinology and Metabolism Sri Lanka College of Endocrinologists, 2021 5(2015), 1, Seite 8-12 (DE-627)1762948362 2012998X nnns volume:5 year:2015 number:1 pages:8-12 https://doi.org/10.4038/sjdem.v5i1.7266 kostenfrei https://doaj.org/article/9e8799477e1041f9af8fd350e80f3b00 kostenfrei https://sjdem.sljol.info/articles/7266 kostenfrei https://doaj.org/toc/2012-998X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 5 2015 1 8-12
language	English
source	In Sri Lanka Journal of Diabetes Endocrinology and Metabolism 5(2015), 1, Seite 8-12 volume:5 year:2015 number:1 pages:8-12
sourceStr	In Sri Lanka Journal of Diabetes Endocrinology and Metabolism 5(2015), 1, Seite 8-12 volume:5 year:2015 number:1 pages:8-12
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	ezscan, diabetes, pre-diabetes Diseases of the endocrine glands. Clinical endocrinology
isfreeaccess_bool	true
container_title	Sri Lanka Journal of Diabetes Endocrinology and Metabolism
authorswithroles_txt_mv	S. Bajaj @@aut@@ R. K. Pandey @@aut@@ A. K. Chaurasia @@aut@@ R. P. Shukla @@aut@@
publishDateDaySort_date	2015-01-01T00:00:00Z
hierarchy_top_id	1762948362
id	DOAJ061703672
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ061703672</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309013317.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2015 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.4038/sjdem.v5i1.7266</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ061703672</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ9e8799477e1041f9af8fd350e80f3b00</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC648-665</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">S. Bajaj</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><p<<strong<<em<Objectives: </em<</strong<Pre-diabetes is almost always a precursor to the development of type 2 diabetes. Comparison of EZSCAN with existing screening methods for detection of pre-diabetes and diabetes was done.</p<<p<<strong<<em<Settings and Design: </em<</strong<Cross sectional epidemiological study.</p<<p<<strong<<em<Material and Methods: </em<</strong<All cases underwent the EZSCAN test and had fasting plasma glucose (FBG), post-prandial plasma glucose (PPBG) and HbA1c level estimation. The results of EZSCAN were compared with fasting blood glucose, post-prandial blood glucose and HbA1c levels.</p<<p<<strong<<em<Statistical analysis used: </em<</strong<Mean, Standard deviation, sensitivity, specificity, positive and negative predictive value.</p<<p<<strong<<em<Results: </em<</strong<The sensitivity and specificity of EZSCAN when compared with FBG in diabetes was 87.2% and 87.2% respectively, for pre-diabetes 80.4% and 74.3% respectively and for non-diabetes 51.1% and 97.8% respectively. The sensitivity and specificity of EZSCAN when compared with PPBG in diabetes was 86.5% and 85.2% respectively, for pre-diabetes 76.9% and 72.6% respectively and for non-diabetes 52.8% and 98.9% respectively. The sensitivity and specificity of EZSCAN when compared with HbA1c in diabetes was 86% and 90.2% respectively, for pre-diabetes 87.8% and 71.4% respectively and for nondiabetes 46.3% and 98.8% respectively.</p<<p<<strong<<em<Conclusions: </em<</strong<EZSCAN proved to be a sensitive, specific, easy to perform screening test for diabetes and pre-diabetes which can be performed in non fasting state. EZSCAN is a simple device that can be operated by non medical personnel in non-healthcare settings with minimal subject preparation.</p<<p<Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2015; 5: 4-7</p<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ezscan, diabetes, pre-diabetes</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the endocrine glands. Clinical endocrinology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">R. K. Pandey</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. K. Chaurasia</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">R. P. Shukla</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Sri Lanka Journal of Diabetes Endocrinology and Metabolism</subfield><subfield code="d">Sri Lanka College of Endocrinologists, 2021</subfield><subfield code="g">5(2015), 1, Seite 8-12</subfield><subfield code="w">(DE-627)1762948362</subfield><subfield code="x">2012998X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:5</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:8-12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.4038/sjdem.v5i1.7266</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/9e8799477e1041f9af8fd350e80f3b00</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://sjdem.sljol.info/articles/7266</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2012-998X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">5</subfield><subfield code="j">2015</subfield><subfield code="e">1</subfield><subfield code="h">8-12</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	S. Bajaj
spellingShingle	S. Bajaj misc RC648-665 misc ezscan, diabetes, pre-diabetes misc Diseases of the endocrine glands. Clinical endocrinology Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods
authorStr	S. Bajaj
ppnlink_with_tag_str_mv	@@773@@(DE-627)1762948362
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RC648-665
illustrated	Not Illustrated
issn	2012998X
topic_title	RC648-665 Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods ezscan, diabetes, pre-diabetes
topic	misc RC648-665 misc ezscan, diabetes, pre-diabetes misc Diseases of the endocrine glands. Clinical endocrinology
topic_unstemmed	misc RC648-665 misc ezscan, diabetes, pre-diabetes misc Diseases of the endocrine glands. Clinical endocrinology
topic_browse	misc RC648-665 misc ezscan, diabetes, pre-diabetes misc Diseases of the endocrine glands. Clinical endocrinology
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Sri Lanka Journal of Diabetes Endocrinology and Metabolism
hierarchy_parent_id	1762948362
hierarchy_top_title	Sri Lanka Journal of Diabetes Endocrinology and Metabolism
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)1762948362
title	Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods
ctrlnum	(DE-627)DOAJ061703672 (DE-599)DOAJ9e8799477e1041f9af8fd350e80f3b00
title_full	Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods
author_sort	S. Bajaj
journal	Sri Lanka Journal of Diabetes Endocrinology and Metabolism
journalStr	Sri Lanka Journal of Diabetes Endocrinology and Metabolism
callnumber-first-code	R
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2015
contenttype_str_mv	txt
container_start_page	8
author_browse	S. Bajaj R. K. Pandey A. K. Chaurasia R. P. Shukla
container_volume	5
class	RC648-665
format_se	Elektronische Aufsätze
author-letter	S. Bajaj
doi_str_mv	10.4038/sjdem.v5i1.7266
author2-role	verfasserin
title_sort	use of ezscan for detection of pre-diabetes and diabetes and comparison with standard screening methods
callnumber	RC648-665
title_auth	Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods
abstract	<p<<strong<<em<Objectives: </em<</strong<Pre-diabetes is almost always a precursor to the development of type 2 diabetes. Comparison of EZSCAN with existing screening methods for detection of pre-diabetes and diabetes was done.</p<<p<<strong<<em<Settings and Design: </em<</strong<Cross sectional epidemiological study.</p<<p<<strong<<em<Material and Methods: </em<</strong<All cases underwent the EZSCAN test and had fasting plasma glucose (FBG), post-prandial plasma glucose (PPBG) and HbA1c level estimation. The results of EZSCAN were compared with fasting blood glucose, post-prandial blood glucose and HbA1c levels.</p<<p<<strong<<em<Statistical analysis used: </em<</strong<Mean, Standard deviation, sensitivity, specificity, positive and negative predictive value.</p<<p<<strong<<em<Results: </em<</strong<The sensitivity and specificity of EZSCAN when compared with FBG in diabetes was 87.2% and 87.2% respectively, for pre-diabetes 80.4% and 74.3% respectively and for non-diabetes 51.1% and 97.8% respectively. The sensitivity and specificity of EZSCAN when compared with PPBG in diabetes was 86.5% and 85.2% respectively, for pre-diabetes 76.9% and 72.6% respectively and for non-diabetes 52.8% and 98.9% respectively. The sensitivity and specificity of EZSCAN when compared with HbA1c in diabetes was 86% and 90.2% respectively, for pre-diabetes 87.8% and 71.4% respectively and for nondiabetes 46.3% and 98.8% respectively.</p<<p<<strong<<em<Conclusions: </em<</strong<EZSCAN proved to be a sensitive, specific, easy to perform screening test for diabetes and pre-diabetes which can be performed in non fasting state. EZSCAN is a simple device that can be operated by non medical personnel in non-healthcare settings with minimal subject preparation.</p<<p<Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2015; 5: 4-7</p<
abstractGer	<p<<strong<<em<Objectives: </em<</strong<Pre-diabetes is almost always a precursor to the development of type 2 diabetes. Comparison of EZSCAN with existing screening methods for detection of pre-diabetes and diabetes was done.</p<<p<<strong<<em<Settings and Design: </em<</strong<Cross sectional epidemiological study.</p<<p<<strong<<em<Material and Methods: </em<</strong<All cases underwent the EZSCAN test and had fasting plasma glucose (FBG), post-prandial plasma glucose (PPBG) and HbA1c level estimation. The results of EZSCAN were compared with fasting blood glucose, post-prandial blood glucose and HbA1c levels.</p<<p<<strong<<em<Statistical analysis used: </em<</strong<Mean, Standard deviation, sensitivity, specificity, positive and negative predictive value.</p<<p<<strong<<em<Results: </em<</strong<The sensitivity and specificity of EZSCAN when compared with FBG in diabetes was 87.2% and 87.2% respectively, for pre-diabetes 80.4% and 74.3% respectively and for non-diabetes 51.1% and 97.8% respectively. The sensitivity and specificity of EZSCAN when compared with PPBG in diabetes was 86.5% and 85.2% respectively, for pre-diabetes 76.9% and 72.6% respectively and for non-diabetes 52.8% and 98.9% respectively. The sensitivity and specificity of EZSCAN when compared with HbA1c in diabetes was 86% and 90.2% respectively, for pre-diabetes 87.8% and 71.4% respectively and for nondiabetes 46.3% and 98.8% respectively.</p<<p<<strong<<em<Conclusions: </em<</strong<EZSCAN proved to be a sensitive, specific, easy to perform screening test for diabetes and pre-diabetes which can be performed in non fasting state. EZSCAN is a simple device that can be operated by non medical personnel in non-healthcare settings with minimal subject preparation.</p<<p<Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2015; 5: 4-7</p<
abstract_unstemmed	<p<<strong<<em<Objectives: </em<</strong<Pre-diabetes is almost always a precursor to the development of type 2 diabetes. Comparison of EZSCAN with existing screening methods for detection of pre-diabetes and diabetes was done.</p<<p<<strong<<em<Settings and Design: </em<</strong<Cross sectional epidemiological study.</p<<p<<strong<<em<Material and Methods: </em<</strong<All cases underwent the EZSCAN test and had fasting plasma glucose (FBG), post-prandial plasma glucose (PPBG) and HbA1c level estimation. The results of EZSCAN were compared with fasting blood glucose, post-prandial blood glucose and HbA1c levels.</p<<p<<strong<<em<Statistical analysis used: </em<</strong<Mean, Standard deviation, sensitivity, specificity, positive and negative predictive value.</p<<p<<strong<<em<Results: </em<</strong<The sensitivity and specificity of EZSCAN when compared with FBG in diabetes was 87.2% and 87.2% respectively, for pre-diabetes 80.4% and 74.3% respectively and for non-diabetes 51.1% and 97.8% respectively. The sensitivity and specificity of EZSCAN when compared with PPBG in diabetes was 86.5% and 85.2% respectively, for pre-diabetes 76.9% and 72.6% respectively and for non-diabetes 52.8% and 98.9% respectively. The sensitivity and specificity of EZSCAN when compared with HbA1c in diabetes was 86% and 90.2% respectively, for pre-diabetes 87.8% and 71.4% respectively and for nondiabetes 46.3% and 98.8% respectively.</p<<p<<strong<<em<Conclusions: </em<</strong<EZSCAN proved to be a sensitive, specific, easy to perform screening test for diabetes and pre-diabetes which can be performed in non fasting state. EZSCAN is a simple device that can be operated by non medical personnel in non-healthcare settings with minimal subject preparation.</p<<p<Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2015; 5: 4-7</p<
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	1
title_short	Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods
url	https://doi.org/10.4038/sjdem.v5i1.7266 https://doaj.org/article/9e8799477e1041f9af8fd350e80f3b00 https://sjdem.sljol.info/articles/7266 https://doaj.org/toc/2012-998X
remote_bool	true
author2	R. K. Pandey A. K. Chaurasia R. P. Shukla
author2Str	R. K. Pandey A. K. Chaurasia R. P. Shukla
ppnlink	1762948362
callnumber-subject	RC - Internal Medicine
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.4038/sjdem.v5i1.7266
callnumber-a	RC648-665
up_date	2024-07-03T22:15:21.520Z
_version_	1803597823627755520
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ061703672</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309013317.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2015 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.4038/sjdem.v5i1.7266</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ061703672</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ9e8799477e1041f9af8fd350e80f3b00</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC648-665</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">S. Bajaj</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><p<<strong<<em<Objectives: </em<</strong<Pre-diabetes is almost always a precursor to the development of type 2 diabetes. Comparison of EZSCAN with existing screening methods for detection of pre-diabetes and diabetes was done.</p<<p<<strong<<em<Settings and Design: </em<</strong<Cross sectional epidemiological study.</p<<p<<strong<<em<Material and Methods: </em<</strong<All cases underwent the EZSCAN test and had fasting plasma glucose (FBG), post-prandial plasma glucose (PPBG) and HbA1c level estimation. The results of EZSCAN were compared with fasting blood glucose, post-prandial blood glucose and HbA1c levels.</p<<p<<strong<<em<Statistical analysis used: </em<</strong<Mean, Standard deviation, sensitivity, specificity, positive and negative predictive value.</p<<p<<strong<<em<Results: </em<</strong<The sensitivity and specificity of EZSCAN when compared with FBG in diabetes was 87.2% and 87.2% respectively, for pre-diabetes 80.4% and 74.3% respectively and for non-diabetes 51.1% and 97.8% respectively. The sensitivity and specificity of EZSCAN when compared with PPBG in diabetes was 86.5% and 85.2% respectively, for pre-diabetes 76.9% and 72.6% respectively and for non-diabetes 52.8% and 98.9% respectively. The sensitivity and specificity of EZSCAN when compared with HbA1c in diabetes was 86% and 90.2% respectively, for pre-diabetes 87.8% and 71.4% respectively and for nondiabetes 46.3% and 98.8% respectively.</p<<p<<strong<<em<Conclusions: </em<</strong<EZSCAN proved to be a sensitive, specific, easy to perform screening test for diabetes and pre-diabetes which can be performed in non fasting state. EZSCAN is a simple device that can be operated by non medical personnel in non-healthcare settings with minimal subject preparation.</p<<p<Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2015; 5: 4-7</p<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ezscan, diabetes, pre-diabetes</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the endocrine glands. Clinical endocrinology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">R. K. Pandey</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. K. Chaurasia</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">R. P. Shukla</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Sri Lanka Journal of Diabetes Endocrinology and Metabolism</subfield><subfield code="d">Sri Lanka College of Endocrinologists, 2021</subfield><subfield code="g">5(2015), 1, Seite 8-12</subfield><subfield code="w">(DE-627)1762948362</subfield><subfield code="x">2012998X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:5</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:8-12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.4038/sjdem.v5i1.7266</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/9e8799477e1041f9af8fd350e80f3b00</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://sjdem.sljol.info/articles/7266</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2012-998X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">5</subfield><subfield code="j">2015</subfield><subfield code="e">1</subfield><subfield code="h">8-12</subfield></datafield></record></collection>
score	7.3981857

Nicht das Richtige dabei?

Schreiben Sie uns!

Use of EZSCAN for detection of pre-diabetes and diabetes and comparison with standard screening methods

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?